Development of a Nonpsychotropic Cannabinoid Agonist for the Treatment of Scleroderma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/17/128/31/13

Funding

  • JB Therapeutics, Inc. (Award Agreement: 11/5/12//1R43AR063)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (Award Agreement: 11/5/12//1R43AR063)